Live Cattle Futures were 50 cents to $1.35 higher at midday, but longs headed for the exit ahead of the close and the pending COF report from USDA. Futures settled…
The S&P 500 Index ($SPX) (SPY) Friday closed down -0.22%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.08%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.43%. September E-mini S&P…
July NY world sugar #11 (SBN25) Friday closed up +0.22 (+1.39%), and August London ICE white sugar #5 (SWQ25) closed down -7.30 (-1.51%).Sugar prices on Friday settled mixed. Short covering…
July NY world sugar #11 (SBN25) today is up +0.18 (+1.13%), and August London ICE white sugar #5 (SWQ25) is down -7.50 (-1.55%).Sugar prices today are mixed. Short covering emerged…
The dollar index (DXY00) Friday fell by -0.21%. The dollar came under pressure Friday on an easing of safe-haven demand after Reuters reported that the Iranian government said it is…
Recent discussions on X about Hims & Hers Health, Inc. (HIMS) have been buzzing with excitement over the company's strategic moves into the weight-loss market, particularly with the introduction of…
Recent chatter on X about Meta Platforms (META) has been buzzing with reactions to the company's intensified focus on artificial intelligence, including potential acquisitions and executive hires. Many users are…
Recent discussions on X about Robinhood Markets, Inc. (HOOD) have been buzzing with activity, largely driven by the company's impressive stock performance and insider confidence. Many users have highlighted a…
All three wheat futures markets were lower on Friday, giving back some of the big Wednesday gains as July options went off the board. The wheat market had rallied at…
The soybean market settled 5 ¼ to 7 ½ lower on Friday, after hitting the highest front month prices since mid-May early in the session. The cmdtyView national average Cash Bean…
July arabica coffee (KCN25) Friday closed down -5.85 (-1.80%), and July ICE robusta coffee (RMN25) closed down -147 (-3.64%).Coffee prices on Friday extended this week’s sharp losses, with robusta sinking…
![Read more about the article Perspective Therapeutics Advances [212Pb]VMT-α-NET Phase 1/2a Study to Cohort 3 with Higher Dosing Strategy](https://sharewatch.com/wp/wp-content/uploads/2025/06/13194-perspective-therapeutics-advances-212pbvmt-23-net-phase-1-2a-study-to-cohort-3-with-higher6857070054e48-768x384.)
Perspective Therapeutics advances [212Pb]VMT-α-NET trial into Cohort 3, assessing higher doses for treating neuroendocrine tumors.Quiver AI SummaryPerspective Therapeutics, Inc. announced that its Phase 1/2a clinical trial for [212Pb]VMT-α-NET is moving…